Daily non-political popular news in brief.
Experimental drug shows promise in advanced kidney cancer
09-26-2007 · EurekAlert!A new drug has shown promise in patients with advanced kidney cancer whose options run out after their tumor fails to respond to the cutting edge therapy. The study, presented today at the European Cancer Conference in Barcelona, showed that the experimental drug, axitinib, shrank tumors and delayed progression of the disease in a group of patients who are among the toughest to treat.
Read more »
Keywords: experimental, drug, shows, promise, advanced, kidney, cancer, show
« Previous | Next »
Similar news on "Experimental drug shows promise in advanced kidney cancer":
- Novel MS drug shows promise in 2 lethal leukemias
08-28-2007 · EurekAlert!
A new study suggests that an experimental drug being tested for the treatment of multiple sclerosis and to prevent organ rejection might also help people with certain deadly forms of chronic and acute leukemia. The laboratory and animal study focused on the drug, called fingolimod. Researchers said it might help patients with advanced chronic myelogenous leukemia or acute lymphocytic leukemia, and whose cancer cells show a particular genetic change called the Philadelphia chromosome.
Similar news · Read more »
- New type of drug shows promise in attacking melanoma in an innovative way
09-26-2007 · EurekAlert!
An experimental drug that attacks cancer in an entirely new way has shown promise in treating advanced melanoma, delaying progression of the disease and prolonging the lives of patients. New research presented today at the European Cancer Conference in Barcelona found that giving the new drug in addition to chemotherapy more than doubled the amount of time patients survived without progression of their cancer.
Similar news · Read more »
- New drug shows promise in treatment of advanced thyroid cancer
06-04-2007 · EurekAlert!
The investigational drug axitinib produced tumor regression or stable disease in almost three-out-of-four patients with advanced thyroid cancer, a research team reported June 3 at the annual meeting of the American Society for Clinical Oncology in Chicago.
Similar news · Read more »
- Anti-cancer drug shows early promise in pulmonary hypertension
11-14-2006 · EurekAlert!
A drug used to treat kidney cancer can prevent the development of pulmonary hypertension in rodents. There is no curative therapy for this condition.
Similar news · Read more »
- Drug that interrupts a key stage of cell division shows promise for advanced solid tumors
11-08-2006 · EurekAlert!
One of the first studies to investigate the effects of a new anti-cancer drug in patients with advanced or metastatic solid tumours has shown that it is capable of halting progression of the disease, and the study has provided the first proof of the drug's mechanism of action, the 18th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Prague was told on Wednesday.
Similar news · Read more »
- Method shows promise for early detection of pancreatic cancer
08-01-2007 · EurekAlert!
Optical technology developed by a Northwestern University biomedical engineer shown to be effective in the early detection of colon cancer now appears promising for detecting pancreatic cancer. A team of Northwestern researchers and Evanston Northwestern Healthcare physicians found they could detect both early- and advanced-stage pancreatic cancer without touching or imaging the pancreas. The new technology could lead to the first screening method for pancreatic cancer in asymptomatic patients.
Similar news · Read more »
- Study finds lapatinib shows promise as therapy for inflammatory breast cancer
12-14-2006 · EurekAlert!
In the first multi-center clinical trial conducted to better understand the complexities of a rare, aggressive and often lethal form of breast cancer, researchers have discovered that the experimental biological agent, lapatinib, successfully and specifically treats inflammatory breast cancer (IBC).
Similar news · Read more »
- Drug shows activity against brain metastases
06-03-2007 · EurekAlert!
The drug lapatinib shrank tumors and slowed progression of brain metastases in some patients with advanced breast cancer, according to results of a clinical trial being presented by Dana-Farber Cancer Institute scientists at the annual meeting of the American Society of Clinical Oncology.
Similar news · Read more »
- Targeting leukemic stem cells by Bcl-2 inhibition
11-17-2006 · EurekAlert!
Researchers at The University of Texas M. D. Anderson Cancer Center have found, in laboratory studies, that the experimental drug ABT-737 which has shown promise in some cancers, can destroy acute myeloid leukemia (AML) blast, progenitor and even stem cells that are often resistant to standard chemotherapy treatment.
Similar news · Read more »
- Promising drug combination may help those with ocular melanoma that has spread
09-04-2007 · EurekAlert!
A combination of two drugs shows promise in treating a rare and therapy-resistant type of melanoma that originates in the eye and spreads to other organs, according to a new study led by Duke University Comprehensive Cancer Center researchers.
Similar news · Read more »
